Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07648524

Influence of Cardiopulmonary Rehabilitation on Cardiorespiratory Adaptation in Patients With Pulmonary Hypertension

This study aims to investigate the effect of cardiopulmonary rehabilitation on cardiorespiratory parameters and functional capacity in patients with pulmonary hypertension.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

45 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of Physical Therapy ,Cairo University

Giza, Egypt

Location contact

Rana Essam El Din Abd Elbar, Assistant lecturer

CONTACT

[email protected]

01013981766

Rana Essam El Din Abd Elbar, assistant lect P.T

CONTACT

[email protected]

About this study

Pulmonary hypertension is a progressive disease associated with reduced exercise capacity, respiratory muscle weakness, and impaired quality of life. Exercise training and respiratory muscle training have been shown to improve physical performance and quality of life in patients with pulmonary hypertension.

forty-two medically stable patients with Group III pulmonary hypertension due to lung diseases (obstructive and restrictive) will participate in this comparative experimental study. Participants will receive cardiopulmonary rehabilitation consisting of moderate-intensity interval aerobic training and inspiratory muscle training in addition to routine medical treatment. Outcome measures will include echocardiographic parameters, pulmonary function, six-minute walk distance, estimated VO2max, dyspnea severity, and quality of life. The study aims to evaluate the influence of cardiopulmonary rehabilitation on cardiorespiratory adaptation in patients with pulmonary hypertension.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • a)Medically stable pulmonary hypertension patients who were under optimized medical therapy. b)Pulmonary artery pressure ≥ 25 mmHg confirmed by RT side heart catheterization.

c)Forty two male patients with group 3 pulmonary hypertension (Chest cause) include Obstructive lung disease ( COPD and sleep apnea ) and restrictive lung disease (ILD). d)The patients' ages will range from 45 to 65 years old. e)BMI (25 - 34.9) kg/m2. f)World Health Organization (WHO) classification of functional classes II to III ( class II are patients with pulmonary hypertension who have a mild limitation of physical activity )(class III are patients with pulmonary hypertension who have a marked limitation of physical activity

Exclusion criteria

  • g)Uncontrolled systemic HTN. h)Other types of pulmonary hypertension.. i)Smoker j)Any condition of kidney failure. k)Neurological or musculoskeletal conditions that interfere with gait

l)Impaired vision and/or hearing.

m)Patients who are unable to follow verbal instructions. n)acute exacerbation condition. o)unstable angina, serious cardiac dysrhythmias on resting ECG.

Treatment and study plan

cardiopulmonary rehabilitation in the form of moderate-intensity interval aerobic training

Behavioral

Training will be conducted on a treadmill three times weekly for 12 weeks. Exercise intensity will progress from 30-40% to 60-70% of target heart rate. Each session will last 30 minutes and include warm-up and cool-down periods.

Inspiratory muscle training

Device

inspiratory muscle training will be performed using a Threshold Inspiratory Muscle Trainer (Philips Respironics). Training intensity will correspond to moderate-to-severe effort (3-5 on the Modified Borg Scale).

Medical treatment

Other

medication

Primary outcomes

  1. 6-minute walk distance

    Time frame: 12 weeks

    total distance walked in 6 minutes

  2. Maximal Oxygen Consumption

    Time frame: 12weeks

    Estimated VO2max

  3. spirometry

    Time frame: 12weeks

    FEV1, FVC, FEV1/FVC, MVV

Secondary outcomes

  1. Dyspnea Severity

    Time frame: 12weeks

    Modified Borg Scale

  2. change Pulmonary Artery Pressure

    Time frame: 12weeks

    pulmonary artery pressure estimated by ECHO

  3. change of total score of SF-12 Questionnaire) Quality of Life

    Time frame: 12weeks

    more increase scores more increase quality of life

Study contacts

Contact information is provided by the study sponsor or research team.

Rana Essam El Din Abd Elbar, Assistant lecturer

CONTACT

[email protected]

01013981766

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Influence of Cardiopulmonary Rehabilitation on Cardiorespiratory Adaptation in Patients With Pulmonary Hypertension: A Comparative Experimental Study

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jun 15, 2026
Registry last updated
Jun 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.